TFDA Approves SteriPlas in Taiwan

It is with great pleasure that we announce the SteriPlas Cold Plasma medical device is now an approved product in Taiwan, making it the first Cold Plasma medical device to be issued in the country. Adtec Healthcare Limited owes its thanks and praises to our exclusive distributor in Taiwan, SG Biomedical, whom without their skills in Regulatory and with the TFDA, none of this would have been possible.

The SteriPlas is already renowned in Taiwan for its strong clinical efficacy using premium and dense Cold Plasma and is set for distribution across the leading hospitals dealing with wound care. This is set to start within the coming months. If you are a health care professional in Taiwan that manages chronic wounds, we humbly request that you contact SG Biomedical who can guide you on the strong antibacterial benefits of the SteriPlas for diabetic foot ulcers, LVAD infections, sternal wounds and many more.

 

http://www.sghlds.com/index.php/tw/

 


SteriPlas will be presented at the ISMCS 2023

Congratulations to Mr Thomas Schlöglhofer who has been invited to speak at the International Society for Mechanical Circulatory Support Scientific Congress (ISMCS) on Wednesday 1st November 2023.

 

His presentation, “Cold Atmospheric Plasma for Driveline Infection Treatment” will focus on the benefits of the SteriPlas for LVAD infections.

 

Our medical device has proven efficacy for the treatment of deep LVAD infections with the presence of biofilm. There is growing interest to use our SteriPlas Cold Plasma for LVAD infections due to its quick ability to destroy bacteria protected within biofilm deep within driveline cavity. This is regardless of the type of bacteria or its resistance profile. As LVAD infections can be healed in as quick as 1 week, it provides stability of the independent system and a better quality of life for patients with LVADs.

 

For more information about the SteriPlas, our clinical evidence or a free trial at your hospital contact us at info@adtecplasma


Adtec Healthcare Ltd to showcase at the LSX Conference in London

We’re on a mission to revolutionize the global wound care market! Adtec Healthcare is participating in the LSX Conference in London.

 

Our managing director, Mary McGovern shall present our cold plasma technology at the MedTech Showcase on Thursday 4th May at 11:30 am.

 

We have developed SteriPlas, a medical device for the treatment of chronic wounds. The most effective cold plasma technology for wound care treatment, proven by clinical studies.  The device uses proven antibacterial cold atmospheric argon plasma to treat chronic wounds, dermatology, and post-operative wound infections.  Enables faster healing, reduces hospital stays, eliminates biofilms and the use of antibiotics. CE Marked and available for sale in UK and EU. Efficacy proven in 70+ peer-reviewed clinical studies.  Early adoption by leading wound care specialists. Strong IP portfolio, comprising of granted and recently submitted patents covering various aspects of their device.

 

We are currently speaking to investors to accelerate sales in Europe and for the launch in the US. At LSX, we are meeting investors and partners interested in medical devices and wound care.

Please contact us at info@adtecplasma.com to arrange a meeting.

 

https://www.lsxleaders.com/lsx-world-congress/agenda/medtech


Thomas presents at the ISHLT show

A fantastic presentation delivered by Thomas Schlöglhofer yesterday at the ISHLT - International Society for Heart and Lung Transplantation show. We hope you got the chance to see his presentation and the promising results he has achieved managing LVAD infections with our Cold Plasma SteriPlas medical device. If you are interested to learn more about the SteriPlas and the benefits it can bring to your patients, please contact us at info@adtecplasma.com

 


Mr Schlöglhofer to present SteriPlas at the ISHLT

Congratulations to Thomas Schlöglhofer from the Medical University of Vienna for his continued success of using our medical device to treat infections in LVAD patients. He will be presenting at The International Society for Heart and Lung Transplantation (ISHLT) conference in April to deliver the great results he has so far achieved.

 

His presentation, “Cold Atmospheric Plasma Therapy: A Powerful Tool for Treating Driveline Infections in Left Ventricular Assist Device Patients” will be during the “Bugs, Drugs, and Thugs: Fighting Infection in VADs Any Way We Can” Session on Wednesday 19th April between 5:30 PM - 6:30 PM.

 

We hope you will be there too to see him deliver his promising results.

 

For more information on how our medical device is fighting against multi resistant bacteria and biofilm in LVAD patients.



Today at The DGTHT Hermedizin 2023

It was a pleasure to see Dr Rotering’s presentation today at the DGTHT Hermedizin 2023 conference. His presentation on the SteriPlas for the treatment of deep sternal wound infections shows just how effective our Cold Plasma medical device is for the treatment of these chronic and deep wounds infected with biofilm.

 

Not only has the SteriPlas has shown to significantly decrease hospital bed occupancy, but it has shown to reduce mortality rates and prevent the need for expensive treatments by allowing sternal wall stability. The SteriPlas can successfully kill all forms of bacteria, regardless of their resistance profile or if they are protected within biofilm.

 


SteriPlas heals wounds quickly

Did you catch the leading Serbian media newspaper, Večernje Novosti, last week? Our SteriPlas was featured in the article, “Cold plasma heals wounds quickly” composed by Dr Zorić.

Dr Zoric has been using our cold plasma medical device to treat hard-to-heal and stalled wounds infected with biofilm. These problematic wounds have responded very well with our SteriPlas treatment and patients have been healed that were otherwise stalled by conventional therapies.

 

If you are within Serbia and interested to learn more about our medical device, contact our medical distributor Borf Health Care on info@borf.biz for more information.

 


Advanced Wound Care Summit Europe 2022

 

It was an honour to present at the Advanced Wound Care Summit Europe conference this week. Our extensive knowledge and library of clinical trials and our history as the experienced leader of Cold Plasma medicine was presented to the audience to bring light to the positive benefits of Adtec Cold Plasma devices.

 

If you would like to hear more about our efficacy and strengths for wounds, surgical site infections and medical dermatology, send us a PM or email us at info@adtecplasma.com


Poster presentation at the DFSG 2022

Did you see Dr Pierides' poster presentation yesterday at the DFSG Diabetic Foot Study Group conference? The poster featured the Adtec SteriPlas success in treating chronic infected diabetic foot ulcers.

The SteriPlas replaced the use of antibiotics for these heavily infected and impacted wounds and had shown remarkable success.


Presentation at the DFSG 2022

We're so excited for exhibiting at the Diabetic Foot Study Group (DFSG) conference next week. Please be sure to visit us at booth no.11 where we will based during the conference. We welcome you to see our SteriPlas Cold Plasma medical device live in action.

We're also excited to announce that the Diabetes Team at Kettering General Hospital NHS Foundation Trust will have a poster presentation illustrating the strong antibacterial efficacy and healing qualities of the Adtec SteriPlas for diabetic foot ulcers.

The poster, "DGH EXPERIENCE OF USING COLD PLASMA MEDICAL DEVICE AS AN ADJUNCT THERAPY TO ANTIMICROBIALS IN TREATING CHRONIC NON HEALING INFECTED DIABETIC FOOT ULCERS" will be presented by Jemma Cruickshank on Saturday 17th September, 13:25 - 14:25.

See you all soon!